Published in J Clin Microbiol on March 01, 2002
Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J Virol (2003) 1.79
Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice. J Virol (2003) 1.12
Efficient delivery of DNA vaccines using human papillomavirus pseudovirions. Gene Ther (2010) 1.02
Role of human papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder cancer among Egyptian patients. Medscape J Med (2008) 0.95
Detection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expressing pseudovirions. Clin Vaccine Immunol (2007) 0.88
A comparative study of two different assay kits for the detection of secreted alkaline phosphatase in HPV antibody neutralization assays. Hum Vaccin Immunother (2015) 0.76
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A (1992) 7.72
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol (1993) 5.12
Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. J Virol (1993) 4.00
Self-assembly of purified polyomavirus capsid protein VP1. Cell (1986) 4.00
In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype. J Virol (1996) 3.66
Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol (1993) 3.65
Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis (2000) 3.36
The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem (1999) 3.16
Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology (1996) 2.83
Polymorphism in the assembly of polyomavirus capsid protein VP1. Biophys J (1989) 2.74
Dissociation of polyoma virus by the chelation of calcium ions found associated with purified virions. J Virol (1977) 2.62
Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol (1997) 2.58
Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins. J Virol (1994) 2.52
Synthesis and assembly of infectious bovine papillomavirus particles in vitro. J Gen Virol (1993) 2.42
Generation and neutralization of pseudovirions of human papillomavirus type 33. J Virol (1997) 2.29
Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes. Virology (2000) 2.25
Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a. J Virol (1987) 2.01
Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence. J Virol (1994) 1.83
Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6. J Virol (1999) 1.66
Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology (1994) 1.64
In vitro construction of pseudovirions of human papillomavirus type 16: incorporation of plasmid DNA into reassembled L1/L2 capsids. J Virol (1998) 1.55
Characterization of a major neutralizing epitope on human papillomavirus type 16 L1. J Virol (1999) 1.52
Expression of the alpha6 integrin confers papillomavirus binding upon receptor-negative B-cells. Virology (1999) 1.45
In vitro gene transfer using human papillomavirus-like particles. Nucleic Acids Res (1998) 1.44
The L2 open reading frame of human papillomavirus type 1a encodes a minor structural protein carrying type-specific antigens. J Virol (1986) 1.41
Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res (1999) 1.38
Assembly of human papillomavirus type 16 pseudovirions in Saccharomyces cerevisiae. Hum Gene Ther (2000) 1.34
Neutralization of human papillomavirus (HPV) pseudovirions: a novel and efficient approach to detect and characterize HPV neutralizing antibodies. Virology (2000) 1.31
The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system. J Clin Microbiol (1998) 1.25
Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions. J Gen Virol (1992) 1.24
In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16. J Virol (1998) 1.20
Susceptibility of various human tissues to transformation in vivo with human papillomavirus type 11. Int J Cancer (1987) 1.19
Self-assembly of human papillomavirus type 16 capsids by expression of the L1 protein in insect cells. FEMS Microbiol Lett (1994) 1.17
Propagation of human papillomavirus type 11 in human xenografts using the severe combined immunodeficiency (SCID) mouse and comparison to the nude mouse model. Virology (1993) 1.09
Baculovirus expression of chimeric hepatitis B virus core particles with hepatitis E virus epitopes and their use in a hepatitis E immunoassay. J Clin Microbiol (1999) 1.09
Polyoma virus pseudocapsids as efficient carriers of heterologous DNA into mammalian cells. Hum Gene Ther (1995) 1.04
Nucleotides 1506-1625 of bovine papillomavirus type 1 genome can enhance DNA packaging by L1/L2 capsids. Virology (1999) 1.00
Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia. J Natl Cancer Inst (1997) 0.93
Interactions of heterologous DNA with polyomavirus major structural protein, VP1. FEBS Lett (1999) 0.91
Calcium is required in reassembly of bovine papillomavirus in vitro. J Gen Virol (1998) 0.88
Cell-free assembly of a polyoma-like particle from empty capsids and DNA. Virology (1979) 0.86
Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology (2004) 4.12
Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J Virol (2003) 1.79
Risk factors of invasive cervical cancer in Mali. Int J Epidemiol (2002) 1.74
Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer (2003) 1.71
High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome. J Clin Oncol (2011) 1.53
Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis (2003) 1.47
Generation of Merkel cell polyomavirus (MCV)-like particles and their application to detection of MCV antibodies. J Clin Microbiol (2010) 1.40
Age-specific seroprevalences of merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and trichodysplasia spinulosa-associated polyomavirus. Clin Vaccine Immunol (2013) 1.36
Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses. J Virol (2002) 1.35
Clinician's guide to human papillomavirus immunology: knowns and unknowns. Lancet Infect Dis (2009) 1.29
Cervical cancer control, priorities and new directions. Int J Cancer (2004) 1.23
Chapter 15: HPV vaccine use in the developing world. Vaccine (2006) 1.23
Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer. Int J Cancer (2002) 1.21
Hepatitis B virus subviral envelope particle morphogenesis and intracellular trafficking. J Virol (2007) 1.16
Seroprevalence of antibodies against human papillomavirus (HPV) types 16 and 18 in four continents: the International Agency for Research on Cancer HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev (2010) 1.16
Merkel cell polyomavirus infection occurs during early childhood and is transmitted between siblings. J Clin Virol (2013) 1.06
Merkel cell polyomavirus strains in patients with merkel cell carcinoma. Emerg Infect Dis (2009) 1.05
Rck of Salmonella enterica, subspecies enterica serovar enteritidis, mediates zipper-like internalization. Cell Res (2010) 1.03
Seroprevalence and cross-reactivity of human polyomavirus 9. Emerg Infect Dis (2012) 1.00
Hepatitis C virus-like particle budding: role of the core protein and importance of its Asp111. J Virol (2003) 0.98
CCL5-enhanced human immature dendritic cell migration through the basement membrane in vitro depends on matrix metalloproteinase-9. J Leukoc Biol (2006) 0.97
Hepatitis E virus seroprevalence and risk factors for individuals in working contact with animals. J Clin Virol (2013) 0.96
Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic. Plant Biotechnol J (2008) 0.96
High hepatitis E virus seroprevalence in forestry workers and in wild boars in France. J Clin Microbiol (2012) 0.95
Saccharomyces cerevisiae modulates immune gene expressions and inhibits ETEC-mediated ERK1/2 and p38 signaling pathways in intestinal epithelial cells. PLoS One (2011) 0.94
Positively charged sequences of human papillomavirus type 16 capsid proteins are sufficient to mediate gene transfer into target cells via the heparan sulfate receptor. J Gen Virol (2003) 0.91
BK virus and cancer in Uganda. Eur J Cancer Prev (2006) 0.91
TFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through tumour-stromal cell interactions. J Cell Mol Med (2011) 0.90
Detection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expressing pseudovirions. Clin Vaccine Immunol (2007) 0.88
Investigation of the prevalence of antibodies against neurotropic polyomaviruses BK, JC and SV40 in sera from patients affected by multiple sclerosis. Neurol Sci (2010) 0.88
Heterogeneity of type III secretion system (T3SS)-1-independent entry mechanisms used by Salmonella Enteritidis to invade different cell types. Microbiology (2010) 0.88
Seroprevalence of human Malawi polyomavirus. J Clin Microbiol (2013) 0.87
Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications. Protein Sci (2009) 0.86
Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs. Mol Cancer Ther (2009) 0.86
Molecular characterization and lytic activities of Streptococcus agalactiae bacteriophages and determination of lysogenic-strain features. J Bacteriol (2009) 0.85
Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodies. J Med Virol (2005) 0.84
Molecular epidemiology of merkel cell polyomavirus: evidence for geographically related variant genotypes. J Clin Microbiol (2014) 0.83
Use of interferon-alpha in two patients with Merkel cell carcinoma positive for Merkel cell polyomavirus. Acta Oncol (2010) 0.83
Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancer. Eur J Immunol (2014) 0.82
Human Merkel cell polyomavirus: virological background and clinical implications. APMIS (2013) 0.81
Positively charged synthetic peptides from structural proteins of papillomaviruses abrogate human papillomavirus infectivity. J Med Virol (2004) 0.80
Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice. Vaccine (2008) 0.79
Drug resistance is affected by colocalization of P-glycoproteins in raft-like structures unexpected in eggshells of the nematode Haemonchus contortus. Biochem Cell Biol (2010) 0.78
The cypovirus Diadromus pulchellus RV-2 is sporadically associated with the endoparasitoid wasp D. pulchellus and modulates the defence mechanisms of pupae of the parasitized leek-moth, Acrolepiopsis assectella. J Gen Virol (2003) 0.77
Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodies. J Transl Med (2010) 0.77
Human papillomavirus type 16 pseudovirions with few point mutations in L1 major capsid protein FG loop could escape actual or future vaccination for potential use in gene therapy. Mol Biotechnol (2014) 0.77
New insights into the mechanisms of fertilization: comparison of the fertilization steps, composition, and structure of the zona pellucida between horses and pigs. Biol Reprod (2009) 0.77
Anti-HPV16 E2 protein T-cell responses and viral control in women with usual vulvar intraepithelial neoplasia and their healthy partners. PLoS One (2012) 0.76
Morphofunctional interactions between galanin and GnRH-containing neurones in the diencephalon of the ewe. The effect of oestradiol. J Chem Neuroanat (2011) 0.76
Newborn pig trachea cell line cultured in air-liquid interface conditions allows a partial in vitro representation of the porcine upper airway tissue. BMC Cell Biol (2014) 0.75
[HPV immunization for the prevention of cervical cancer]. Presse Med (2009) 0.75
Somatostatin Receptors 2A and 5 Are Expressed in Merkel Cell Carcinoma with No Association with Disease Severity. Neuroendocrinology (2015) 0.75
[Vaccination against human papillomavirus infections]. Rev Prat (2006) 0.75
Recurrent primary cutaneous mucinous carcinoma with neuroendocrine differentiation: case report and review of the literature. J Cutan Pathol (2014) 0.75
[Merkel cell carcinoma: a virus-induced tumor?]. Presse Med (2008) 0.75